“Certolizumab Pegol for the Treatment of Patients With Moderate-to-Severe Chronic Plaque Psoriasis: An Overview of 3 Randomized Controlled Trials”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S3. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/306.